Dysregulation of miR-374a is involved in the progression of diabetic retinopathy and regulates the proliferation and migration of retinal microvascular endothelial cells

References

• Ye Z, Li ZH, He SZ. miRNA-1273g-3p involvement in development of diabetic retinopathy by modulating the autophagy-lysosome pathway. Med Sci Monit. 2017;23:5744–5751.
   PubMed Web of Science ®Google Scholar
• Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ. 2020;369:m997.
   PubMedGoogle Scholar
• Platania CBM, Maisto R, Trotta MC, et al. Retinal and circulating miRNA expression patterns in diabetic retinopathy: an in silico and in vivo approach. Br J Pharmacol. 2019;176:2179–2194.
   PubMed Web of Science ®Google Scholar
• Martinez B, Peplow PV. MicroRNAs as biomarkers of diabetic retinopathy and disease progression. Neural Regen Res. 2019;14:1858–1869.
   PubMed Web of Science ®Google Scholar
• Yoon HJ, Cho YZ, Kim JY, et al. Correlations between glucagon stimulated C-peptide levels and microvascular complications in type 2 diabetes patients. Diabetes Metab J. 2012;36:379–387.
   PubMedGoogle Scholar
• Berrocal MH, Acaba LA, Acaba A. Surgery for diabetic eye complications. Curr Diab Rep. 2016;16:99.
   PubMed Web of Science ®Google Scholar
• Chen B, Yang W, Zhao H, et al. Abnormal expression of miR-135b-5p in bone tissue of patients with osteoporosis and its role and mechanism in osteoporosis progression. Exp Ther Med. 2020;19:1042–1050.
   PubMed Web of Science ®Google Scholar
• Liao Z, Sun H, Chang Y, et al. The expression and clinical significance of miRNA-183 in cerebral ischemia-reperfusion injury patients with cerebral small vessel disease. Ann Transl Med. 2020;8:1005.
   PubMed Web of Science ®Google Scholar
• Ge X, Guo M, Hu T, et al. Increased microglial exosomal miR-124-3p alleviates neurodegeneration and improves cognitive outcome after rmTBI. Mol Ther. 2020;28:503–522.
   PubMed Web of Science ®Google Scholar
• Bao XY, Cao J. MiRNA-138-5p protects the early diabetic retinopathy by regulating NOVA1. Eur Rev Med Pharmacol Sci. 2019;23:7749–7756.
   PubMed Web of Science ®Google Scholar
• Shao Y, Dong LJ, Takahashi Y, et al. miRNA-451a regulates RPE function through promoting mitochondrial function in proliferative diabetic retinopathy. Am J Physiol Endocrinol Metab. 2019;316:E443–E452.
   PubMed Web of Science ®Google Scholar
• Yang X, Yu X, Zhou RH, et al. Serum miRNA-27b-3p is a biomarker of diabetic retinopathy. J Biol Regul Homeost Agents. 2020;34:1431–1435.
   PubMed Web of Science ®Google Scholar
• Ji H, Yi Q, Chen L, et al. Circulating miR-3197 and miR-2116-5p as novel biomarkers for diabetic retinopathy. Clin Chim Acta. 2020;501:147–153.
   PubMed Web of Science ®Google Scholar
• Qing S, Yuan S, Yun C, et al. Serum miRNA biomarkers serve as a fingerprint for proliferative diabetic retinopathy. Cell Physiol Biochem. 2014;34:1733–1740.
   PubMedGoogle Scholar
• Stepien EL, Durak-Kozica M, Kaminska A, et al. Circulating ectosomes: determination of angiogenic microRNAs in type 2 diabetes. Theranostics. 2018;8:3874–3890.
   PubMed Web of Science ®Google Scholar
• American Diabetes A (7) approaches to glycemic treatment. Diabetes Care. 2015;38(Suppl):S41–48.
   PubMedGoogle Scholar
• Wilkinson CP, Ferris FL 3rd, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110:1677–1682.
   PubMed Web of Science ®Google Scholar
• Gu C, Draga D, Zhou C, et al. miR-590-3p inhibits pyroptosis in diabetic retinopathy by targeting NLRP1 and inactivating the NOX4 signaling pathway. Invest Ophthalmol Vis Sci. 2019;60:4215–4223.
   PubMed Web of Science ®Google Scholar
• Jain A, Chen S, Yong H, et al. Endothelin-1 traps potently reduce pathologic markers back to basal levels in an in vitro model of diabetes. J Diabetes Metab Disord. 2018;17:189–195.
   PubMed Web of Science ®Google Scholar
• Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50.
   PubMed Web of Science ®Google Scholar
• Ma J, Wang J, Liu Y, et al. Comparisons of serum miRNA expression profiles in patients with diabetic retinopathy and type 2 diabetes mellitus. Clinics (Sao Paulo). 2017;72:111–115.
   PubMed Web of Science ®Google Scholar
• Li EH, Huang QZ, Li GC, et al. Effects of miRNA-200b on the development of diabetic retinopathy by targeting VEGFA gene. Biosci Rep. 2017;37:BSR20160576.
   PubMed Web of Science ®Google Scholar
• Gong Q, Li F, Xie J, et al. Upregulated VEGF and Robo4 correlate with the reduction of miR-15a in the development of diabetic retinopathy. Endocrine. 2019;65:35–45.
   PubMed Web of Science ®Google Scholar
• Simo-Servat O, Simo R, Hernandez C. Circulating biomarkers of diabetic retinopathy: an overview based on physiopathology. J Diabetes Res. 2016;2016:5263798.
   PubMed Web of Science ®Google Scholar
• Hajmousa G, Przybyt E, Pfister F, et al. Human adipose tissue-derived stromal cells act as functional pericytes in mice and suppress high-glucose-induced proinflammatory activation of bovine retinal endothelial cells. Diabetologia. 2018;61:2371–2385.
   PubMed Web of Science ®Google Scholar
• Zhu K, Hu X, Chen H, et al. Downregulation of circRNA DMNT3B contributes to diabetic retinal vascular dysfunction through targeting miR-20b-5p and BAMBI. EBioMedicine. 2019;49:341–353.
   PubMed Web of Science ®Google Scholar
• Wang M, Wei J, Shang F, et al. Down-regulation of lncRNA SNHG5 relieves sepsis-induced acute kidney injury by regulating the miR-374a-3p/TLR4/NF-kappaB pathway. J Biochem. 2021.
   Web of Science ®Google Scholar
• Lu T, Zhang C, Chai MX, et al. MiR-374a promotes the proliferation of osteosarcoma cell proliferation by targeting Axin2. Int J Clin Exp Pathol. 2015;8:10776–10783.
   PubMed Web of Science ®Google Scholar
• Prabu P, Rome S, Sathishkumar C, et al. Circulating MiRNAs of ‘Asian Indian Phenotype’ identified in subjects with impaired glucose tolerance and patients with type 2 diabetes. PLoS One. 2015;10:e0128372.
   PubMed Web of Science ®Google Scholar
• Shao D, He S, Ye Z, et al. Identification of potential molecular targets associated with proliferative diabetic retinopathy. BMC Ophthalmol. 2020;20:143.
   PubMed Web of Science ®Google Scholar
• Wang Z, Liu Y, Shao M, et al. Combined prediction of miR-210 and miR-374a for severity and prognosis of hypoxic-ischemic encephalopathy. Brain Behav. 2018;8:e00835.
   PubMed Web of Science ®Google Scholar
• Kim Y, Sim J, Kim H, et al. MicroRNA-374a expression as a prognostic biomarker in lung adenocarcinoma. J Pathol Transl Med. 2019;53:354–360.
   PubMed Web of Science ®Google Scholar
• Ji R, Zhang X, Gu H, et al. miR-374a-5p: a new target for diagnosis and drug resistance therapy in gastric Cancer. Mol Ther Nucleic Acids. 2019;18:320–331.
   PubMedGoogle Scholar
• Bastawrous A, Burgess PI, Mahdi AM, et al. Posterior segment eye disease in sub-Saharan Africa: review of recent population-based studies. Trop Med Int Health. 2014;19:600–609.
   PubMed Web of Science ®Google Scholar
• Fukushima S, Nakagami T, Suto C, et al. Prevalence of retinopathy and its risk factors in a Japanese population. J Diabetes Investig. 2013;4:349–354.
   PubMed Web of Science ®Google Scholar
• Silveira EA, De Souza Rosa LP, De Carvalho Santos A, et al. Type 2 diabetes mellitus in class II and III obesity: prevalence, associated factors, and correlation between glycemic parameters and body mass index. Int J Environ Res Public Health. 2020;11:3930.
   Google Scholar
• Tomita Y, Shao Z, Cakir B, et al. An ex vivo choroid sprouting assay of ocular microvascular angiogenesis. J Vis Exp. 2020;1940–087x.
   Web of Science ®Google Scholar
• Zeng Q, Liu J. Silencing circ_0001879 inhibits the proliferation and migration of human retinal microvascular endothelial cells under high-glucose conditions via modulating miR-30-3p. Gene. 2020;760:144992.
   PubMed Web of Science ®Google Scholar
• Wu L, Guo F, Wu Y, et al. The role of FoxO1 in interleukin-1beta-induced autostimulation in retina endothelial cells and retinas of diabetic rats. Microvasc Res. 2017;112:93–100.
   PubMed Web of Science ®Google Scholar
• Ni W, Luo L, Zuo P, et al. miR-374a inhibitor enhances etoposide-induced cytotoxicity against glioma cells through upregulation of FOXO1. Oncol Res. 2019;27:703–712.
   PubMed Web of Science ®Google Scholar
• He W, Feng L, Xia D, et al. MiR-374a promotes the proliferation of human osteosarcoma by downregulating FOXO1 expression. Int J Clin Exp Med. 2015;8:3482–3489.
   PubMed Web of Science ®Google Scholar